Research and Development

Abbott has announced positive data from two separate studies, which looked at its TriClip transcatheter edge-to-edge repair (TEER) system and …

Following positive data from Eli Lilly’s phase 3 monarchE trial, the FDA has granted approval for the expanded indication for …

A collaborative study between Sanofi and Sobi called XTEND-Kids phase 3 has finished, solidifying the first milestone needed for regulatory …

BioNxt Solutions, a bioscience accelerator focused on next-generation drug formulations and delivery systems, has announced the finalisation of its comparative …

Sequana Medical has shared positive results from its phase 1 trial, CHIHUAHUA, assessing the safety and tolerability of a single …

Biotech company CSL has reported positive results from its phase 3 trial for garadacimab, a monthly treatment for hereditary angioedema …

BiomX has shared data from a new study in cystic fibrosis (CF) patients, assessing whether bacteriophages could be a new …

UK-based clinical-stage biotech company Redx Pharma has agreed to a $425m all-share merger with US drug research business Jounce Therapeutics. …

Pharmaceutical companies Karyopharm Therapeutics and Menarini Group have announced that the UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) have …

Beckley Psytech, a private, clinical-stage biotech company, announced that the FDA has granted Investigational New Drug (IND) approval for their …

The FDA is expected to approve Pfizer’s new respiratory syncytial virus (RSV) vaccine this summer following its acceptance of the …

Hemab Therapeutics announced it received $135m from their oversubscribed Series B funding round. The funding will be used for their …

Scancell Holdings PLC have shared early results from its phase 1/2 cancer study which appear “very encouraging”, according to one …

Scancell Holdings PLC has shared “highly encouraging” results from its phase 1 clinical trial of its COVID-19 vaccines, says chief …

SynaptixBio, a UK-based biotech firm, has been granted FDA Rare Paediatric Disease (RPD) designation – an accolade which encourages the …